Asia Pacific drives over 30% of global beauty and personal care value. Beauty cycles across Korea, Japan, and China are becoming harder to read. The challenge is separating short-lived social media signals from ingredients with real technical depth, while also tracking domestic Chinese innovation that often receives less attention than Korea and Japan.

The webinar is built for teams already close to the science, but looking for a sharper view of which beauty trends have technical depth, competitive momentum, and room for product differentiation

You’ll get answers to

• How to separate durable Asian beauty ingredient platforms from short-lived TikTok-led signals, especially across K-beauty, J-beauty, and C-beauty cycles.
• Which emerging Asian beauty ingredients, including PDRN, exosomes, spicule serums, and actives used in neurocosmetics, have clinical backing versus marketing momentum.
• What C-beauty brands such as Proya, Florasis, and Winona are building in formulation, format, and efficacy claims that many Western innovation teams have not yet closely mapped.
• How to predict which Korean and Japanese beauty trends have structural global potential versus those likely to remain regional or campaign-led.
• How to identify credible co-development partners across Chinese, Korean, and Japanese IP, ingredient, and regulatory environments.
• How Thailand’s OEM/ODM strength and natural ingredient base can support ASEAN expansion strategies.

Join the webinar to avoid treating every fast-moving Asian beauty trend as an opportunity. We’ll show which ingredients, formats, partners, and regional signals have enough evidence, scalability, and differentiation potential to shape your next product launch.

The post Asian Beauty Trends: Innovation Insights From China, Japan, Korea, and Thailand appeared first on GreyB.

The post AI in Patent Search:The Pitfalls No OneTalks About appeared first on GreyB.

Energy is just one piece. The deeper cost driver is process efficiency itself.

Fermentation unit economics are highly sensitive to scale, yield, and process variability, widely known as the TRY metrics (titer, rate, yield). These metrics directly influence the cost of production, thus increasing the cost of goods sold (CoGS) and commercial viability. 

This has resulted in a new wave of platforms targeting upto 70% cost reductions through continuous fermentation, AI-driven strain design, and smarter downstream processing. 

Join the webinar to find out how companies like Cauldron, GEA, and Fermeate are cutting costs by 30–70%, and the technologies you can scale today vs the ones still in pilot-stage promise. 

You’ll Walk Away Knowing

• What’s keeping bio-manufactured ingredients from reaching cost parity with conventional alternatives?
• Which lever among Titer, Rate, and Yield matters most in reducing production costs at an industrial scale?
• How are companies like EV Biotech and Neoncorte Bio replacing trial and error strain development with digital twins and predictive metabolic modeling?
• Where membrane cost savings directly impact DSP economics?
• How are Cauldron and NoshBio cutting CAPEX by 45–70% without sacrificing consistency or yield?       

The fermentation products market is growing. Alternative proteins, industrial enzymes, probiotics, and bio-based chemicals all point toward a future where biological manufacturing displaces petrochemical and agricultural production.

Don’t miss the live discussion

Get access to the full research, Q&A with analysts, and on-demand replay.

The post Cut Fermentation Cost Without Sacrificing Scale-Up Performance appeared first on GreyB.

Learn how to show which patents in your portfolio map are commercially deployed to 5G features across target verticals.

Why This Webinar, Why Now

For years, portfolio size helped shape licensing conversations. That is changing.

As 5G licensing expands beyond smartphones into automotive, IoT, RedCap, and satellite-enabled markets, implementers are asking harder questions. They are no longer satisfied with broad declarations or a handful of representative patents. They want to know which parts of a portfolio actually map to features their products use, which releases those features belong to, and whether those features are commercially deployed at scale.

That shift is raising the bar for licensors.

Without a clear way to connect patents to real-world deployment, licensing teams risk longer deal cycles, tougher pushback, and weaker rate discussions. This webinar is designed to help solve that problem.

What You’ll Learn

In this webinar, GreyB will walk through a practical framework for presenting 5G portfolio strength with more technical precision and commercial credibility.

You will learn how to:

• assess portfolio relevance at the feature level rather than relying only on total declared volume
• map patents against 3GPP Release 15, 16, and 17 features
• distinguish foundational 5G coverage from peripheral or commercially irrelevant coverage
• evaluate which features are actually deployed across automotive, IoT, RedCap, satellite, and smartphone use cases
• use deployment-backed analysis to support stronger positioning in licensing discussions

The challenge is no longer just how to present portfolio strength. The real issue is that the evidence standard has changed.

Licensors entering new verticals are increasingly met with questions such as:

• How much of this portfolio actually applies to our product category?
• Which patents map to features that are in commercial use today?
• How much of the claimed value comes from smartphone-centric features that are irrelevant to our products?

If those questions are not answered clearly, even a large portfolio can lose persuasive force in negotiation. Your team may have strong patents, but without deployment-backed context, that strength becomes harder to prove.

Join the Webinar

See how a deployment-mapped, feature-tagged view of your 5G portfolio can help you enter licensing discussions with greater confidence and clearer evidence.

The post You are Going to Get a Higher 5G Licensing Rate in Automotive & IoT in 2026 appeared first on GreyB.

Meanwhile, implementers are quietly asking a different question, not how many LTE patents you have, but how many of them actually matter for a constrained, low-power, narrowband device.

Those are two very different numbers. And your competitors already know the difference.

The IoT licensing market is not behaving like the handset market. Implementers are not just pushing back on rates; they are challenging the premise that a full LTE portfolio justifies royalties on a device that implements 60% of LTE.

And they are right to ask.

The licensors who are winning in this environment are not the ones with the biggest declared portfolios. They are the ones who can walk in and say: here is exactly which LTE-M capabilities our patents cover, here is the feature adoption data across the device market, and here is why our portfolio is more relevant to your products than any other licensor at this table.

This webinar teaches you how to build that position.

What You’ll Walk Away With

A framework to map your portfolio specifically to LTE-M capabilities, not LTE overall.

LTE-M operates across a defined set of technical layers: narrowband operation, half-duplex communication, coverage enhancement, power saving, and reduced complexity. We show you how to score your portfolio against each one and where you lead.

A way to prove you are more relevant than competing licensors technically, not just commercially.

Portfolio size is a starting point. Feature-level relevance is the argument that closes deals. We show you how to build a licensing narrative around LTE-M core SEPs, LTE foundational SEPs, and the extended LTE patents that weigh your portfolio down in an IoT negotiation.

A benchmark of how major LTE portfolios actually score when mapped to LTE-M devices.

The ranking looks different when the lens is LTE-M. Some licensors move up significantly. Others have been overestimating their position for years. Know where you stand before your next negotiation tells you.

A defensible differentiation story you can take into any licensing conversation.

Not “we have X declared families.” But “our portfolio covers Y% of LTE-M core capabilities, higher than any competing licensor.” That is the conversation that shifts leverage.

The Three-Step Framework We Will Cover

Step 1: Build your LTE-M capability taxonomy. Understand exactly which technical layers LTE-M devices actually implement — and which LTE features never show up in an IoT product.

Step 2: Score your portfolio against it. Separate your SEPs into three buckets: LTE-M core, LTE foundational, and LTE extended. Know which bucket drives your real licensing leverage in IoT negotiations.

Step 3: Benchmark against competing licensors. See where your portfolio leads, where it is exposed, and how to construct a differentiation argument that holds up under technical scrutiny.

If Your Licensing Argument Is Still “We Have a Large LTE Portfolio,” This Changes That.

Register for Free for a technically defensible position you can use in your next LTE-M licensing negotiations.

The post Your LTE Portfolio Is Strong. But Is It Strong For LTE-M? appeared first on GreyB.

You walk into a licensing negotiation with 400 declared patents. They walk in knowing exactly which of those patents cover features their products don’t even use.

This webinar shows you how to close that gap before it costs you a deal.

What You’ll Walk Away With

Find out which of your patents are actually making you money and which are just costing you credibility.

We analysed 3,900+ certified Wi-Fi 6 products to show which features the market actually adopted. The patents that cover those features are your real assets. The rest are deadweight when a licensee pulls out a teardown.

See exactly where you’re undercharging.

Portfolio rankings look completely different when measured by real product usage rather than declaration count. Most licensors discover they’ve been leading with the wrong patents entirely and underpricing the ones that actually stick.

Walk in with a list of targets and provable exposure.

Company-level data showing which manufacturers are using the features your patents cover. Not estimates. Actual product data you can put in front of a licensee and make it very hard to argue with.

A framework to restructure how you negotiate, starting with your next meeting.

Which families to open with? Which to set aside. How to shift the conversation from “how many patents do you have” to “here’s exactly what your products are using.” The second position closes deals. The first one starts arguments.

Why This Matters Right Now

Licensees, especially large device makers and chipset vendors are doing their homework before they sit down with you. They know which features their products use. They know which of your patents don’t apply to them. And they’re using that to push back on your rates, shrink the scope of deals, and drag out negotiations.

This isn’t a new risk. It’s already happening.

The CalTech case against Apple and Broadcom resulted in $1.1 billion in damages and it turned entirely on which features the products actually used, not how many patents were declared. The EU is now moving toward requiring proof of real-world use for standard-essential patents. Licensees are already challenging pool rates on exactly this basis.

There’s a difference between saying “we have 400 patents” and saying “these 60 patents cover a feature present in 96% of certified products, including yours.” The second position wins. This webinar shows you how to build it.

Who This Is For

• Licensing heads who want to increase deal value without adding a single patent to their portfolio
• IP counsel and strategy teams tired of long negotiations that settle for less than they should
• M&A and valuation teams who need to know what a portfolio is genuinely worth, not what the declaration count implies
• Anyone with a Wi-Fi 6 licensing conversation in the next 6 months

45 minutes. Real data. A clearer picture of what your portfolio is actually worth.

$2.6 Billion Is the Market. Claim your share of it with this FREE Webinar!

The post STOP Licensing Your Wi-Fi 6 Patents Wrong. Here’s What the Number Should Actually Be. appeared first on GreyB.

Global sodium intake is running at more than double WHO’s recommended limit. Regulators are tightening targets. Retailers are exploring sodium reduction solutions. And consumers say they want less salt, right up until the moment they taste it.

The formulation challenge isn’t just taste. It’s that beyond saltiness, sodium drives texture, controls microbial stability, supports processing efficiency, and masks off-notes that re-emerge the moment you pull it back. Swapping in KCl gets you to 20%, but the trade-offs are higher, bitterness surfaces, texture shifts, and shelf life margins shrink.

This webinar breaks down what PepsiCo, Unilever, Mars, and emerging ingredient players are actually patenting and deploying, and which approaches are genuinely scalable.

Inside the Discussion

• Why does sodium reduction consistently fail beyond the 30–40% threshold in real food matrices?
• What are companies like PepsiCo (Frito-Lay), General Mills, Mars, and Unilever actually patenting in sodium reduction?
• How are Frito-Lay and Unilever restoring texture and processing stability in low-sodium products?
• Are receptor-targeted technologies from players like General Mills and Tasteomics redefining salt perception?
• Which innovations are truly scalable versus just pilot-stage promise?

If your team is still exploring sodium reduction solutions that don’t break texture, shelf life, or consumer liking, you have to be in the room. Join us for a live discussion.

The post Can your low sodium formula pass every test: Cost, safety, and consumer acceptance? appeared first on GreyB.

The EU’s BPA ban is in effect, banning BPA and five additional hazardous bisphenols across plastics, coatings, inks, adhesives, and silicones used in food contact materials. With the compliance deadline for most single-use FCMs by July 2026, packaging teams have limited time to assess exposure, identify alternatives, and validate compliant solutions. Products manufactured with BPA that don’t comply cannot be placed on the EU market after this date.

Join this webinar to understand how leading companies are navigating this transition towards BPA-free packaging by balancing compliance, innovation, and long-term risk.

What You’ll Walk Away With:

• Which materials are in, which are out, and where the regulation’s exceptions create both temporary relief and long-term risk.
• How to systematically identify BPA dependency across product lines, including epoxy can coatings, reusable plastics, adhesive laminates, and printed packaging
• Which BPA-free packaging replacements are currently in development?
• How to evaluate waterborne, polyester, and non-bisphenol systems against regulatory durability, not just technical performance.
• How to screen alternatives for endocrine disruption and future restriction potential before committing to reformulation? (so you’re not solving a 2026 problem and creating one for 2029)
• How leading packaging companies are structuring their transition: suppliers, material innovations, process changes, and accredited migration testing priorities.

Still Evaluating Your BPA Exposure? Don’t wait until compliance deadlines force reactive decisions. Register now. (Seats are limited to keep the Q&A useful)

The post Beyond BPA: Future-Proof Your Food Packaging Under EU’s Bisphenol Crackdown appeared first on GreyB.

Consumers say that their skin still feels dry, tight, or flaky even after routine skincare. Despite this, most formulations rely on humectants that sit only on the surface of the skin and struggle to deliver stress-resilient hydration.

Even glorified humectants like hyaluronic acid fail under environmental conditions, making skin even drier as they pull moisture from the skin.

This has pushed R&D teams to innovate hydration that meets cellular resilience. Osmolytes in skin care are gaining attention in research, patents, and ingredient launches, yet remain under-adopted in mainstream hydration strategies.

This webinar explores why osmolytes are quickly becoming the future of moisture barrier and how leading companies like L’Oréal and Kao Corporation are building a competitive edge.

You’ll get answers to

• How are leading players (brands, suppliers, startups) using osmolytes to keep the moisture barrier?
• Which osmolyte class should you focus on for your next product formulation?
• How are emerging startups innovating in osmolyte-based skin care?

All grounded in peer-reviewed literature, clinical signals, patent activity, and real products using osmolytes for skin and hair care. 

If you are working on your next 12–24-month hydration roadmap, you have to be in the room!

Fill the form to register for the webinar

The post Hydration Beyond Hyaluronic: Is Your Product Ready for Barrier Support? appeared first on GreyB.

You’re about to see it happen live.

The Problem You’re Living With Right Now

• 6-7 hours per claim chart (if you’re lucky)
• Months waiting for a complete portfolio analysis
• 20% coverage of declared SEP families at best
• Incomplete data driving million-dollar licensing decisions

100,000+ declared 3GPP patent families exist. Your team can manually analyze what, maybe 50 this quarter Not to forget, traditional methods are slow, error-prone, and inefficient, costing you valuable time and money.

It’s time for a change.

Introducing the AI SEP Mapping Tool

This AI-powered tool cuts your analysis time by up to 98%, without compromising on accuracy. Here’s how:

• Instant Analysis: Map patent claims to specification sections in minutes, not hours.
• Cross-Standard Coverage: Analyze across 5G/6G (3GPP), Wi-Fi 6/7 (802.11ax/be), and Video Codecs (HEVC/VVC).
• Pre-Built Claim Charts: Automatically generate 70%-complete draft claim charts, reducing your team’s effort from 7 hours per chart to just a 30-minute final review.
• Proven Accuracy: With 80-85% accuracy, validated through independent benchmarking, the tool distinguishes essential SEPs from implementation patents.
• Built for Scale: Process entire portfolios in days, not months, with consistent analysis methodology across all patents.

What You’ll See Live

Three Real-World Use Cases to Show how the Tool fits into your SEP Analysis.

Ultimately, the question will not be whether you need better SEP analysis, but rather if you can afford to continue doing it the old way.

Get the recording now and see the difference AI can make to your SEP Analysis.

The post AI is Taking Standard Essential Patent Analysis from 7 Hours to a Few Minutes appeared first on GreyB.